News
North Union notched a school record for goals scored in a girls soccer game as the Lady Cats defeated Pleasant 19-1 on Saturday at NU. Kale Keigley had five goals for North Union (3-0-1), tying a ...
While Gilead Sciences posted a strong Q2 earnings print, GILD stock saw profit-taking. Here's why the red ink could be an ...
CVS Health, one of the nation’s largest pharmacy benefit managers, has declined to cover Gilead’s newly FDA-approved HIV ...
6h
Dealbreaker on MSNGilead Sciences Gains In Vivo Cell Therapy Capability With $350M Interius Bio Acquisition
Kite, the Santa Monica, California-based cell therapy subsidiary of Gilead, has entered a definitive agreement to pay $350 ...
Imdelltra is a first-in-class immunotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC) marketed by Amgen Royalty ...
Fort Worth’s oldest African American Baptist church, which was recently put on a list of Most Endangered Places in the city, ...
3d
TipRanks on MSNGilead Sciences Advances Lung Cancer Treatment with New Clinical Study
Gilead Sciences (($CC:GILD.CUR)) announced an update on their ongoing clinical study. Gilead Sciences, in collaboration ...
Gilead subsidiary Kite Pharma said that it has acquired Interius BioTherapeutics and its single-shot CAR-T program for $350 million.
The Gilead HIV prevention shot , called Yevtugo, is highly effective, but its list price is $28, 218 a year in the U.S.
Gilead Sciences Inc. (NASDAQ: GILD) is one of the most undervalued quality stocks to buy according to hedge funds. On July 25, the European Medicines Agency’s Committee for Medicinal Products ...
US Stock Market indexes S&P 500, Nasdaq, and Dow Jones made weekly gains as Gilead Sciences Inc (GILD) and Expedia Group Inc (EXPE) stocks are rising.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results